Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicentric, Randomized, Double-blind, Parallel, Phase IV Study to Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke

NCT05955326 is registered in ClinicalTrials.gov with Pharmazz, Inc. as lead sponsor.

NCT NCT05955326
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05955326 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicentric, Randomized, Double-blind, Parallel, Phase IV Study to Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
Lead sponsor
Pharmazz, Inc.
Phase
Phase 4
Overall status
Active, not recruiting
Start date
January 8, 2024
Completion date
December 18, 2026
Enrollment
160 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

acute cerebral ischemia